Hi FMF, its actually better than good. AKIDA as you pointed at gets a mention at Figure 4 (you underlined it).
The reason its better than good is that Loihi is still only in research - so that only leaves us.
Honestly, I wouldn’t rely on it anymore… we’re basically swinging from one “hope vine” to the next — from one company to another that mentions BrainChip or experiments with Akida. After so many years, we should know by now that this doesn’t really mean anything. Potential investors aren’t impressed by vague statements and name-drops. What’s been said here many times remains true: what we need now is a sustainable deal with real products that generates actual revenue. Only then will investors come back in. The share price can be as cheap as it wants — right now, we long-term investors are holding the price up simply because we’re not selling. That’s all. We don’t even need more speculation anymore… I think we’ve already slipped on that too many times, personally. IMO DYOR no financial advice